Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-26 @ 12:36 AM
Study NCT ID:
NCT00304460
Status:
COMPLETED
Last Update Posted:
2019-12-12
First Post:
2006-03-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03-13
Start Date Type:
None
Primary Completion Date:
2014-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-16
First Submit QC Date:
None
Study First Post Date:
2006-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-11
Last Update Post Date:
2019-12-12
Last Update Post Date Type:
ACTUAL